心房纤颤并发冠状动脉疾病患者的抗栓治疗研究进展被引量：1

下载PDF

导出

摘要约1／3的心房纤颤患者同时患有冠状动脉疾病^[1]。临床医师常遇见的难题是对有高危卒中风险（CHADS：评分≥2）需给予口服抗凝药物而同时有冠状动脉疾病又需给予抗血小板药物甚至双联抗血小板药物的心房纤颤患者如何治疗的问题，

作者赵梦华石建平刘吉祥

机构地区河北省邯郸市中心医院

出处《医学研究杂志》 2013年第5期20-22,共3页 Journal of Medical Research

关键词冠状动脉疾病心房纤颤抗栓治疗患者抗血小板药物并发口服抗凝药物临床医师

分类号 R541.4 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献1

1Andrea Rubboli.Antithrombotic management of patients on oral anticoagulation undergoing coronary artery stenting[J].World Journal of Cardiology,2010,2(3):64-67. 被引量：4

二级参考文献31

1Ho PM,Maddox TM,Wang L,Fihn SD,Jesse RL,Peterson ED,Rumsfeld JS.Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. The Journal of The American Medical Association . 2009
2O‘Donoghue ML,Braunwald E,Antman EM,Murphy SA,Bates ER,Rozenman Y,Michelson AD,Hautvast RW,Ver Lee PN,Close SL,Shen L,Mega JL,Sabatine MS,Wiviott SD.Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhib-itor: an analysis of two randomised trials. The Lancet . 2009
3Dewilde W,Berg JT.Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST). American Heart Journal . 2009
4The ACTIVE Writing Group on behalf of the ACTIVE Investigators.Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial Fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet,The . 2006
5Karjalainen PP,Vikman S,Niemel M,Porela P,Ylitalo A,Vaittinen MA,Puurunen M,Airaksinen TJ,Nyman K,Vahlberg T,Airaksinen KE.Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment. European Heart Journal . 2008
6Sarafoff N,Ndrepepa G,Mehilli J, et al.Aspirin and clopidogrel with or without phenprocoumon after drug eluting coronary stent placement in patients on chronic oral anticoagulation. Journal of Internal Medicine . 2008
7Ruiz-Nodar JM,Marín F,Sánchez-Payá J,Hurtado JA,Valencia-Martín J,Manzano-Fernández S,Roldán V,PérezAndreu V,Sogorb F,Valdés M,Lip GY.Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation. European Heart Journal . 2009
8Hlg C,Brunner-La Rocca HP,Kaiser C,Jeger R,Osswald S,Pfisterer M,Hoffmann A.Early and late increased bleeding rates after angioplasty and stenting due to combined antiplatelet and anticoagulanttherapy. EuroIntervention . 2009
9Rubboli A,Colletta M,Sangiorgio P,Di Pasquale G.Antithrombotic treatment after coronary artery stenting in patients on chronic oral anticoagulation: an international survey of current clinical practice. Italian Heart Journal . 2004
10Rubboli A,Schlitt A,Airaksinen J,Lip GY.Bleeding after coronary stenting in patients on oral anticoagulation: who is guilty. EuroIntervention . 2010